Neuraltus Pharmaceuticals Lands $14,938,357 New Funding Round

  • Feed Type
  • Date
    5/25/2016
  • Company Name
    Neuraltus Pharmaceuticals
  • Mailing Address
    2479 E. Bayshore Road Palo Alto, CA 94303 USA
  • Company Description
    Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing innovative small molecule therapeutics for the treatment of neurodegenerative disorders.
  • Website
    http://www.neuraltus.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,938,357
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy